CVS Health Corp. diskutieren
CVS Health Corp.
WKN: 859034 / Symbol: CVS / Name: CVS Health / Aktie / Lebensmittel- & Medikamentenhandel / Large Cap /
84,20 €
0,84 %
CVS Health (CVS) had its price target raised by DA Davidson from $80.00 to $100.00. They now have a "buy" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health (CVS) had its price target raised by Deutsche Bank Aktiengesellschaft from $88.00 to $92.00. They now have a "buy" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health (CVS) had its "outperform" rating reaffirmed by Royal Bank Of Canada.
Ratings data for CVS provided by MarketBeat
CVS Health (CVS) had its "buy" rating reaffirmed by TD Cowen.
Ratings data for CVS provided by MarketBeat
CVS Health (CVS) had its price target raised by JPMorgan Chase & Co. from $101.00 to $111.00. They now have an "overweight" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health (CVS) had its price target raised by Sanford C. Bernstein from $94.00 to $106.00. They now have an "outperform" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health (CVS) had its price target raised by Morgan Stanley from $93.00 to $106.00. They now have an "overweight" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health (CVS) had its price target raised by Argus from $90.00 to $104.00. They now have a "buy" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health (CVS) was given a new $110.00 price target by Mizuho. They now have an "outperform" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health (CVS) had its price target raised by Barclays PLC from $101.00 to $106.00. They now have an "overweight" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health (CVS) had its "overweight" rating reaffirmed by Piper Sandler.
Ratings data for CVS provided by MarketBeat
CVS Health (CVS) had its price target raised by Truist Financial Corporation from $102.00 to $108.00. They now have a "buy" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health (CVS) had its "overweight" rating reaffirmed by Morgan Stanley.
Ratings data for CVS provided by MarketBeat
CVS Health (CVS) had its price target raised by UBS Group AG from $100.00 to $115.00. They now have a "buy" rating on the stock.
Ratings data for CVS provided by MarketBeat
Neueste Beiträge
Raymond_James in Dexcom Inc. diskutieren